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Summary
Background: The presence and severity of coronary artery disease may be underestimated in
patients who do not reach signiﬁcant end-points of stress testing during myocardial perfusion
imaging. We examined how the effect of the level of exercise may affect the ability of the
quantitative gated single-photon emission computed tomography (SPECT) imaging to predict
the future cardiac events (cardiac death, non-fatal myocardial infarction and severe heart
failure).
Method: Of the 4629 consecutively registered patients for J-ACCESS (Japanese-assessment of
cardiac event and survival study by quantitative gated SPECT), 2821 patients who underwent
the exercise test were selected, and divided into two groups, which reached a target heart
rate (group; n = 925) or not (n = 1896). Leg fatigue was the most common reason for stopping
the exercise test in non-reaching groups, we conducted a study comparing group with leg fatigue
group (group II).
low-up period, total of 25 cardiac events (2.7%) occurred in group IResults: During a 3-year fol
and total of 73 events (3.9%) occurred in group II. The incidence of cardiac death was slightly
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but signiﬁcantly higher in group II (P.04). A summed stress score (SSS) was able to separate
the high-risk from low-risk patients in group II. The maximal heart rate was not an independent
predictor for cardiac events. In Cox multivariate regression analysis, higher age (70 years), history
of DM, EDV at rest and LVEF at rest were predictor of cardiac major events (cardiac death,
myocardial infarction, heart failure), and higher age (70 years), ESV at rest were independent
predictor of cardiac hard events (cardiac death, myocardial infarction) in group II.
Conclusion: Exercise SPECT imaging provides the useful prognostic information in patients who
do not reach a signiﬁcant end-point due to the leg fatigue. In such patients, those with normal
ESV
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(CABG), recurrent angina and non-severe heart failure were
classiﬁed as soft events, and death (cardiac death andSSS score and normal resting
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he prognosis of patients who had normal results of the exer-
ise stress test is excellent [1]. But if the exercise stress test
oes not reach a signiﬁcant exercise load, the diagnosis and
everity of coronary artery disease might be underestimated
2]. Although the usefulness of gated stress/rest myocar-
ial perfusion single-photon emission computed tomography
SPECT) imaging for prediction of future cardiac events has
een proven [3,4]. The limitation and usefulness of gated
PECT for risk stratiﬁcation in patients who do not achieve
dequate exercise end-points due to most common reason,
ow leg fatigue, are not fully investigated. Accordingly, we
onducted the study to examine whether the stress gated
PECT imaging is useful for risk stratiﬁcation of coronary
rtery disease in patients with not only adequate but sub-
aximal exercise, based on the database from J-ACCESS
Japanese-assessment of cardiac event and survival study by
uantitative gated SPECT) study. The multicenter J-ACCESS
tudy is the ﬁrst prognostic investigation in Japan to evalu-
te the role of myocardial perfusion SPECT in patients with
oronary artery disease [5].
tudy population
he design, entry criteria and protocol of J-ACCESS study
as been previously published [6]. The study group con-
isted of 4629 patients (2989 men, mean age 64.9± 10.3
ears; 1640 women, mean age 67.2± 9.7 years) been sched-
led to undergo stress/rest gated SPECT for the diagnosis
f coronary artery disease and the prediction of patient
rognosis. Exclusion criteria from initial registration were
nset of myocardial infarction or unstable angina pectoris
ithin 3 months, valvular disorder, idiopathic cardiomyopa-
hy, severe arrhythmia, heart failure of class III or higher on
he New York Heart Association classiﬁcation, and severe
iver or renal disorders. The most frequent complication
f registered patients was hypertension (54.5%), followed
y dyslipidemia (47.2%), and diabetes mellitus (29.4%). The
PECT examinations were ordered for further examination
f chest pain (32.8%), periodic follow-up after PCI (24.2%),
creening for coronary artery disease (15.1%), follow-up of
he myocardial infarction (14.9%), more detailed investi-
ation of ECG or echocardiographic abnormalities (13.1%),
tiological assessment of heart failure (1.6%). The methods
f stress used were most exercise (68.8%) [ergometer 76.5%,
readmill 23.5%], dipyridamole (14.6%) or adenosine triphos-
hate (ATP; 13.8%). The follow-up investigations were over
years. The registration period was from October 1, 2001
n
u
I
p
(have also a most favorable prognosis.
ology. Published by Elsevier Ireland Ltd. All rights reserved.
o March 31, 2002. The investigators were asked to com-
ly with the Declaration of Helsinki, and for their Institute
eview Boards to approve their participation in the study in
rinciple, and to receive the written informed consent of
ach patient who participated in this survey.
Of 4629 registered patients for J-ACCESS study, 2821 were
ubjected to this study, Nine hundred twenty-ﬁve patients
chieved adequate exercise end-points deﬁned as greater
r equal to 85% of maximal predicted heart rate (target
eart rate), without angina and positive electrocardiograms.
ther 1896 patients were divided into 6 groups due to the
nd-points of exercise stress; non-reaching predicted heart
ate group; lower leg fatigue (n = 1460), chest pain (n = 85),
igniﬁcant ST-T changes (n = 178), serious arrhythmia (n = 5),
ypotension (n = 4) and others (n = 164). Lower leg fatigue
as the most common reason for submaximal exercise test
n this study.
PECT imaging
PECT scan was performed using technetium-99m-
etrofosmin (99mTc-tetrofosmin). The SPECT acquisition
aried depending on the performance of medical facilities.
he variations are previously reported [6]. The SPECT
mages were divided into 20 segments, and visual perfusion
cores for 99mTc-tetrofosmin uptake in individual segments
ere scored in ﬁve stages as described by Berman et al.
0 = normal, 1 =mildly reduced, 2 =moderately reduced,
= severely reduced, 4 = absent uptake) [7]. The summed
tress score (SSS) and summed rest score (SRS) obtained
rom these each segments, and the left ventricular ejection
raction (LVEF), end-diastolic volume (EDV) and end-systolic
olume (ESV) were obtained from the QGS analysis.
ollow-up survey
he investigation periods were 3 years after the registra-
ion. In J-ACCESS study, Percutaneous coronary intervention
PCI) including plain old balloon angioplasty (POBA), stent-
ng, directional coronary atherectomy (DCA), and rotablator
therectomy, as well as coronary artery bypass graftingon-cardiac death), myocardial infarction, and heart fail-
re requiring hospitalization were classiﬁed as hard events.
n this study, according to the representative’s principal
aper [5], cardiac death and non-fatal myocardial infarction
MI) were classiﬁed as hard cardiac events. Cardiac death,
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non-fatal MI and severe heart failure which required the
hospitalization were classiﬁed as major cardiac events.
Analysis and statistics
Continuous variables are expressed as averages± standard
deviations (SD). We applied the unpaired t-test to compare
results from patients with and without cardiac events. The
chi square test was used for categorical data. The associa-
tion of selected variables with outcome was assessed with
the Cox proportional hazard model using univariate analysis
and stepwise multivariable procedures. A p-value less than
0.05 considered statistically signiﬁcant. All statistical calcu-
lations were performed with Statistical analysis system 9.1.3
(SAS Institute, USA) computer program.
Results
Patients groups for analysis
On the basis of level of exercise and exercise end-points,
the patients were divided into two groups; group 1 (n = 925)
achieved ≥85% of maximal predicted heart rate but nega-
tive electrocardiographic changes; group II (n = 1460) were
leg fatigue as symptomatic end-points at the submaximal
exercise level, deﬁned as failure to achieve at least 85%
of the maximal predicted heart rate; In these patients the
exercise ECGs were interpreted as inconclusive.
The relationship between clinical characteristics of study
patients and cardiac major events between groups I and
II in Table 1. Patients with cardiac major events in group
I were higher frequency usage rate of Ca antagonist. The
other hands, those in group II were higher age (>70 years),
gender male, prevalence of myocardial infarction, smoking,
usage rate of nitrate and history of DM.Scintigraphic results in two groups
The comparison of gated SPECT variables in two groups was
shown in Table 2. Resting ESV and resting EDV were larger,
F
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i
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Figure 1 Kaplan—Meier analysis of cardiac event free survival base
difference among groups in the incidence of major cardiac events b53
nd LVEF at rest was lower in group 1 with cardiac events.
ore clearly resting ESV and resting EDV were larger, and
VEF at rest was lower, the SSS, SRS and SDS were signiﬁ-
antly higher in group II with cardiac events.
ardiac events in two groups
uring the 3-year follow-up, a major cardiac event occurred
n 25 patients (2.7%) of group I [5 cardiac deaths (0.54%),
1 non-fatal myocardial infarction (1.19%), 9 severe heart
ailure (0.97%)] and 73(3.9%) in group II [22 cardiac deaths
1.54%), 22 non-fatal myocardial infarction (1.51%), 29
evere heart failure (1.99%)] (Table 3). Incidentally, the
umbers of PCI were 57(6.1%) and 78(5.3%) in groups I and II,
espectively (p = 0.45). The numbers of CABG were 4(0.4%)
nd 12(0.8%) in groups I and II, respectively (p = 0.03).
able 4 shows Cox univariate regression analysis for prognos-
ic indicators in group II. Higher age (>70 years), prevalence
f myocardial infarction, history of DM, SSS score, resting
SV, resting EDV, resting LVEF, HR post-stress and double
roduct were predictors of major cardiac events in group
I.
In Cox multivariate regression analysis, higher age (>70
ears), history of DM, resting EDV and resting LVEF were
redictor of cardiac major events, and higher age (>70
ears), resting ESV were independent predictor of cardiac
ard events in group II (Table 5). Cox univariate regression
nalysis for prognostic indicators in group I, resting ESV and
esting EDV were predictors of cardiac events. However the
igniﬁcant independent predictor of cardiac events was not
ound in Cox multivariate regression analysis (Table 6).
ardiac events and SSS in group IIig. 1 shows the major cardiac event-free survival curves
f the four category groups, which been classiﬁed SSS value
nto normal, mildly, moderately and severely abnormal. The
ncidence of cardiac events in groups with normal or mildly
bnormal SSS values was signiﬁcantly lower than those of
d on SSS values in all patients of group II. There was signiﬁcant
y SSS values (p < 0.0001 by 2 trend test).
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Table 1 Comparison of the clinical background of the cardiac major events and non-cardiac major events between groups I and II.
Group I Group II
Major event (n = 22) No major event (n = 903) p-Value Major event (n = 61) No major event (n = 1399) p-Value
Age 67.7± 9.5 64.6± 9.7 0.1469 68.9± 9.9 64.5± 10.3 0.0013
Male 19/22(86.4%) 597/903(66.1%) 0.0782 51/61(83.6%) 949/1399(67.8%) 0.0141
Body weight 61.5± 11.0 60.9± 10.6 0.7756 59.0± 10.8 61.7± 10.9 0.0666
History of angina (n/total%) 10/22(45.5%) 322/903(35.7%) 0.4106 27/61(44.3%) 589/1399(42.1%) 0.8042
History of MI 10/22(45.5%) 247/903(27.4%) 0.0750 32/61(52.5%) 433/1399(31.0%) 0.0005
History of revascularization 11/22(50.0%) 307/903(34.0%) 0.1848 27/61(44.3%) 540/1399(38.6%) 0.3412
Smoking 4/22(18.2%) 132/903(14.6%) 0.6139 18/61(29.5%) 211/1399(15.1%) 0.0090
Hypertension 15/22(68.2%) 430/903(47.6%) 0.0997 34/61(55.7%) 739/1399(52.8%) 0.8016
Diabetes mellitus 10/22(45.5%) 231/903(25.6%) 0.0683 31/61(50.8%) 405/1399(28.9%) 0.0007
Dyslipidemia 6/22(27.3%) 419/903(46.4%) 0.0995 24/61(39.3%) 678/1399(48.5%) 0.2024
Nitrate 9/22(40.9%) 344/903(38.1%) 0.9695 34/61(55.7%) 570/1399(40.7%) 0.0322
Ca antagonist 15/22(68.2%) 366/903(40.5%) 0.0182 29/61(47.5%) 662/1399(47.3%) 1.0000
ACE-I 5/22(22.7%) 175/903(19.4%) 0.9132 20/61(32.8%) 320/1399(22.9%) 0.1109
ARB 3/22(13.6%) 99/903(11.0%) 0.9652 11/61(18.0%) 177/1399(12.7%) 0.3188
 blocker 5/22(22.7%) 134/903(14.8%) 0.4739 21/61(34.4%) 384/1399(27.4%) 0.3180
MI: myocardial infarction.
Table 2 Comparison of gated SPECT variables of the cardiac major events and non-cardiac major event between groups I and II.
Group I Group II
Major event (n = 22) No major event (n = 903) p-Value Major event (n = 61) No major event (n = 1399) p-Value
HR at rest (bpm) 75.9± 14.6 76.7± 14.3 0.7846 73.9± 13.7 70.4± 12.4 0.0318
SBP at rest (mmHg) 151.5± 25.3 143.0± 22.3 0.0785 148.3± 24.4 142.0± 22.0 0.0309
HR post-stress 139.1± 10.5 142.3± 15.0 0.3235 117.5±22.9 123.0± 20.2 0.0391
SBP post-stress (mmHg) 206.2± 32.5 202.5± 30.5 0.5740 186.9± 37.7 194.9± 32.4 0.0611
Accumulation type normal (n/total, %) 7/22(31.8%) 462/903(51.2%) 0.1147 15/61(24.6%) 658/1399(47.0%) 0.0009
Reversal or reversal and persistent (n/total, %) 8/22(36.4%) 232/903(25.7%) 0.3777 20/61(32.8%) 374/1399(26.7%) 0.3706
SSS 10.9± 12.8 7.4± 10.7 0.1359 16.6± 15.5 7.9± 10.6 <0.0001
SRS 9.5± 13.1 6.5± 10.3 0.1812 14.6± 15.2 6.5± 9.8 0.0001
EDV at rest (ml) 110.2± 60.0 82.6± 31.7 0.0431 118.2± 61.4 85.5± 33.0 0.0001
ESV at rest (ml) 55.9± 46.0 33.7± 24.7 0.0345 67.3± 55.7 35.3± 25.8 <0.0001
LVEF at rest (%) 55.8± 14.7 62.6± 12.4 0.0125 49.8± 16.8 62.2± 12.5 <0.0001
EDV post-stress (ml) 93.3± 47.5 80.7± 32.7 0.3609 110.5± 64.8 82.8± 33.4 0.0094
ESV post-stress (ml) 48.9± 44.8 34.0± 26.2 0.2539 62.9± 58.5 34.9± 26.6 0.0040
LVEF post-stress (%) 54.5± 17.2 61.5± 12.7 0.0539 49.5± 16.5 61.3± 12.6 <0.0001
SSS: summed stress score; SRS: summed rest score; EDV: end-diastolic volume; ESV: end-systolic volume; LVEF: left ventricular ejection fraction.
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Table 3 Cardiac events during follow-up period (3 years).
Group I Group II p-Value
Cardiac death 5(0.54%) 22(1.54%) 0.0483
Non-cardiac death 23(2.49%) 37(2.53%) 1.0
Non-fatal myocardial infarction 11(1.19%) 22(1.51%) 0.6403
Heart failure requiring hospitalization 9(0.97%) 29(1.99%) 0.0788
PCI: percutaneous catheter intervention.
Table 4 Cox univariate prognostic predictor of cardiac major events in group II.
Wald 2 HR 95% CI p-Value
Lower Upper
Age 10.5203 1.050 1.019 1.081 0.0012
Gender; male 6.2996 2.382 1.209 4.692 0.0121
Myocardial infarction 12.2776 2.476 1.491 4.112 0.0005
Risk factor: HT 0.1515 1.106 0.667 1.832 0.6971
Risk factor: DM 11.9641 2.425 1.468 4.006 0.0005
Risk factor: dyslipidemia 2.0245 0.687 0.410 1.152 0.1548
SSS 34.5201 1.047 1.031 1.064 <0.0001
Resting ESV 70.8205 1.017 1.013 1.021 <0.0001
Resting EDV 53.0236 1.015 1.011 1.018 <0.0001
Resting LVEF 55.4283 0.940 0.924 0.955 <0.0001
HR post-stress 4.5335 0.987 0.975 0.999 0.0332
.992
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This study demonstrated exercise SPECT imaging providesSBP post-stress 3.6191 0
Double product (>25,000) 4.823 0
MI: myocardial infarction; ACE-I: angiotensin converting enzyme i
moderately or severely abnormal SSS values. In patients with
greater normal SSS <4, major cardiac event occurred in 16
patients (2.2%) in follow-up period. Kaplan—Meier analysis
curves for major cardiac events demonstrates signiﬁcant
better prognosis in patients with normal than those with
abnormal scintigraphic results (Fig. 2).
Cardiac events and EDV, ESV in group II
Although EDV, ESV and stroke volume are affected a lot by
gender, age and body weight, we used threshold EDV values
of 130ml and 90ml for male and females, in additionally,
threshold ESV values of 60ml and 40ml, respectively. Each of
higher EDV and higher ESV was associated with signiﬁcantly
Table 5 Cox multivariate prognostic predictors in group II.
Wald 2 HR
Cardiac hard event
Age 6.8809 1.060
ESV at rest 37.043 1.017
Cardiac major event
Age 10.4982 1.051
Risk factor DM 5.2669 1.836
EDV at rest 3.8425 1.007
LVEF at rest 9.6432 0.959
DM: diabetes mellitus; ESV: end-systolic volume; LVEF: left ventricular
t
n
i
r0.985 1.000 0.0571
0.305 0.935 0.0281
tor; ARB: angiotensin receptor blocker.
igher incidence of major cardiac events in group II (13.64%
s. 2.88%, 12.56% vs. 2.8%). Kaplan—Meier analysis curves for
ajor cardiac events demonstrates signiﬁcant poor progno-
is in patients with higher EDV (≥130ml for male and ≥90ml
or female) and higher ESV (≥60ml for male and ≥40ml for
emale) by measured by gated SPECT (Figs. 3 and 4).
iscussion95% CI p-Value
Lower Upper
1.015 1.107 0.0087
1.0101 1.022 <0.0001
1.020 1.083 0.0012
1.093 3.084 0.0217
1.000 1.014 0.0500
0.933 0.985 0.0019
ejection.
he useful prognostic information even in patients who do
ot reach a signiﬁcant end-point due to the leg fatigue and
n such patients, those with normal SSS score and normal
esting ESV have also a most favorable prognosis. Although
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Table 6 Univariate and multivariate logistic regression analysis for cardiac events in group I.
Wald 2 HR 95% CI p-Value
Lower Upper
Cox univariate regression analysis
SSS 0.1292 1.013 0.943 1.089 0.7192
SRS 0.0967 1.012 0.941 1.087 0.7558
EDV at rest 5.2853 1.015 1.002 1.029 0.0215
ESV at rest 4.9199 1.018 1.002 1.003 0.0265
LVEF at rest 2.3374 0.954 0.899 1.013 0.1263
Cox multivariate regression analysis
SSS 0.0097 1.017 0.726 1.425 0.9214
SRS 0.1004 0.947 0.678 1.323 0.7513
EDV at rest 0.2133 1.019 0.941 1.103 0.6442
ESV at rest 0.0073 0.995 0.88 1.124 0.9319
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tLVEF at rest 0.2221 0.968
SSS: summed stress score; SRS: summed rest score; EDV: end-dias
fraction.
he previous study has shown that the incidence of abnor-
al images were lower in patients with submaximal exercise
han those with adequate exercise [2], the ability of SPECT
maging for prediction of future cardiac event has been
nknown in relatively low-risk populations. We conﬁrmed
he role of gated SPECT for predicting future cardiac events
n patients studied.
The incidence of cardiac death in patients with submaxi-
al exercise was slightly, but signiﬁcantly, higher than those
ith adequate exercise end-points (p < 0.04). Our data also
how that gated SPECT ﬁndings provide the incremental and
ndependent prognostic value above clinical assessment in
atients who do not reach signiﬁcant exercise end-points. In
articular, both assessment of perfusion and left ventricu-
ar volume by gated SPECT are useful for risk stratiﬁcation.
e Winter et al. have previously reported that the SDS
summed difference score) and resting end-systolic volume
≥70ml) were independent predictors of cardiac death [8].
t
p
g
A
w
igure 2 Kaplan—Meier estimates for major cardiac events accord
o severely abnormal, n = 745). There was signiﬁcant difference in th0.845 1.109 0.6374
volume; ESV: end-systolic volume; LVEF: left ventricular ejection
n this present study, it was conﬁrmed that resting ESV was
he strongest independent predictor of cardiac hard events.
lthough EDV, ESV and stroke volume are affected a lot by
ender, age and body weight, we adopted threshold EDV
alue of 130ml and 90ml, and threshold ESV value of 60ml
nd 40ml from some of J-ACCESS studies [9,10].
The utility of SSS score is also established as the prog-
ostic predictors of the cardiac events for decades [11—13].
ase on the J-ACCESS study, SSS category most useful predic-
or for cardiac events in Japanese populations [5,10,14,15].
owever, in this present study, it was not a signiﬁcant pre-
ictor for both cardiac hard events and cardiac major events
y Cox multivariate regression analysis in patients who have
he submaximal exercise. Meanwhile normal SSS score in
atients who have the submaximal exercise can provide the
ood negative predictive value for future cardiac events.
lthough it was apprehensive that the diagnosis of patients
ith normal stress myocardial perfusion imaging in group II
ing to SSS values. SSS < 4 (normal, n = 715), SSS≥ 4 (from mildly
e incidence of major cardiac events in two groups.
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cFigure 3 Kaplan—Meier estimates for major cardiac events
software. Male patients with EDV <130ml and EDV ≥130ml. Fem
difference in the incidence of major cardiac events both group
might be underestimated, the results suggest that the prog-
nosis of patients with both normal SSS score (≤3) and normal
ESV(<60ml in male, <40ml in female) might be excellent and
favorable.
Equally, group I with good exercise tolerance showed
favorable prognosis. The average annual cardiac hard events
rate in patients with adequate exercise tolerability was
0.6%. The prognosis of patients who had normal results of
the exercise stress test is excellent [1]. The Duke treadmill
score categories are previously known to provide prognos-
tic information, and it was known high exercise tolerance
is associated with an excellent prognosis [1]. Naturally, it
is thought either the higher SSS or the maximal heart rate
reﬂected their low cardiac function and severe ischemia.
However, in group I, resting ESV and resting EDV were predic-
tors of cardiac events by Cox univariate regression analysis.
f
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Figure 4 Kaplan—Meier estimates for major cardiac events accord
ware. Male patients with ESV <60ml and ESV ≥60ml. Female pat
difference in the incidence of major cardiac event both groups for mording to EDV obtained from resting gated SPECT using QGS
atients with EDV <90ml and EDV ≥90ml. There was signiﬁcant
males and females.
oreover, although the maximal heart rate was predictors
f major cardiac events by Cox univariate regression analy-
is in group II, either SSS score or the maximal heart rate
as not an independent predictor for cardiac events. In
his present study, lower leg fatigue was the most common
eason for submaximal exercise test. The average pressure-
ate product in group II was 23,897 (mmHg×bpm), the
alue was high but not signiﬁcant for end-points. This was
ikely due to the type of exercise used in J-ACCESS study,
ecause ergometer exercise is the common method of exer-
ise stress test in Japan and tends to be stopped by leg
atigue before reaching the target heart rate. The signiﬁ-
ant difference in medication rate of the -blocker used was
ound between groups I and II (15% vs. 27.7%, p < 0.0001).
lthough -blocker was discontinued for at least 12 h before
he test, the -blocker might affect the diagnostic sensitiv-
ing to ESV obtained from resting gated SPECT using QGS soft-
ients with ESV <40ml and ESV ≥40ml. There was signiﬁcant
ales and females.
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[
[8
ty in exercise test because of a tendency earlier stopping
he exercise by leg fatigue before reaching the target heart
ates. In the sub-study in J-ACCESS Ueshima et al. reported
SS score and the maximal heart rate were independent pre-
ictors of cardiac major events [15]. The reason of different
esults between our and their studies might be that they
nitially classiﬁed the patient groups according to SSS score
nd heart rate score, and excluded the patients who took
-blockers from the analysis. But we included the patients
ho took -blockers in this study, because of supposing the
xercise stress test in real world.
There are some limitations in this study. First, the present
tudy was based on a multicenter registry database. The
PECT imaging data were interpreted from 117 participat-
ng hospitals. Therefore, we were repeatedly trained in
mage interpretation to reduce inter-institute variability,
nd sampling studies were added to conﬁrm the variability
f scoring. Second, the cardiac events rate in this popula-
ion may be lower because previous study has indicated that
atients who are able to exercise test are at lower risk than
hose who underwent pharmacological stress test [10]. Addi-
ionally, this study population and number of cardiovascular
vents may not be sufﬁcient to analyze the inﬂuence of SSS
nd the maximal heart rate during exercise on these events.
onclusion
his study showed gated SPECT imaging is useful to the
isk stratiﬁcation for patients who could not reach a signif-
cant end-point at the exercise stress test. The prognosis
f patients with both normal SSS score (≤3) and normal
SV(<60ml in male, <40ml in female) is good and favorable
egardless of submaximal exercise level.
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